Objective: Cardiac resynchronization therapy (CRT) induces structural and electrical reverse remodeling of the failing heart. However, the association between native QRS narrowing and cardiac fibrosis markers has not been investigated in patients with an implanted CRT device. Methods: A total of 41 symptomatic patients diagnosed with systolic heart failure who underwent CRT implantation were included in this study. Electrocardiogram findings and cardiac fibrosis marker levels [galectin-3, growth-differentiation factor-15 (GDF-15) and procollagen III N-terminal propeptide (P3TD)] were collected before and 12 months after initiation of biventricular pacing. Reverse electrical remodeling was defined as a decrease in 12-month intrinsic QRS (iQRS) duration by ≥20 milliseconds after CRT implantation. Results: The median QRS duration decreased from 155 milliseconds (interquartile range [IQR]: 142-178 milliseconds) before CRT to 142 milliseconds (IQR: 130-161 milliseconds) (p=0.001) after 12 months of CRT. According to the predefined criteria, electrical remodeling was detected in 16 (39.0%) patients. The median galectin-3, GDF-15, and P3TD levels were significantly decreased after CRT implantation in patients with electrical remodeling [27.65 ng/mL (IQR: 24.4-35.2 ng/mL) vs 23.00 ng/mL (IQR: 16.0-36.7 ng/mL), p=0.017; 3104 pg/mL (IQR: 2923-4825 pg/mL) vs 2276 pg/mL (IQR: 1294-3209 pg/ mL), p=0.002; 0.43 ng/mL (IQR: 0.23-0.64) vs 0.15 ng/mL (IQR: 0.04-0.29 ng/mL), p=0.034, respectively]. The galectin-3, GDF-15, and P3TD levels were not significantly changed in patients without electrical remodeling [26.80 ng/mL (IQR: 23.9-31.5 ng/ mL) vs 28.80 ng/mL (IQR: 23.0-34.8 ng/mL), p=0.211; 4221 pg/ mL (IQR: 2709-4995 pg/mL) vs 3035 pg/mL (IQR: 2038-4872 pg/mL), p=0.143; and 0.34 ng/mL (IQR: 0.11-0.68 ng/mL) vs 0.21 ng/mL (IQR: 0.09-0.37 ng/mL), p=0.112, respectively].
Amaç: Kardiyak resenkronizasyon tedavisi (KRT) kalp yetersizliğinde yapısal ve elektriksel ters yeniden şekillenmeyi uyarmaktadır. Ancak, KRT yerleştirilmiş hastalarda QRS'teki daralma ile kalp fibrozu belirteçleri arasındaki ilişki daha önce araştırılmamıştır. Yöntemler: Semptomlu sistolik kalp yetersizliği bulunan ve KRT yerleştirilmiş 41 hasta çalışmaya alındı. Elektrokardiyografi bulguları ve kalp fibrozu belirteç seviyeleri (galektin-3, büyüme farklılaşma faktörü-15 I n a failing heart, prolonged ventricular conduction time is associated with heart failure progression and a poor outcome. QRS widening causes dyssynchronous ventricular contraction due to dispersion of ventricular depolarization, resulting in intra-and interventricular mechanical dyssynchrony. Cardiac resynchronization therapy (CRT) is a valuable treatment option for patients with severe heart failure and left ventricular conduction disturbances that reduces both morbidity and mortality. [1, 2] CRT reduces the heterogeneity of ventricular contraction with biventricular stimulation and causes mechanical remodeling of the ventricles. In CRT, biventricular stimulation usually results in an immediate narrowing of the paced QRS-complex and a reduction in left ventricular chamber size, as well as improvement in ejection fraction. The extent of the QRS shortening induced by biventricular pacing seems to correlate with the structural remodeling. Despite optimal management of patients, nearly 30% do not respond to CRT. In this regard, evaluation of electrical remodeling in conjunction with structural remodeling may be useful for patient selection and follow-up. As paced QRS duration is imperfect in assessing the impact on underlying electrical remodeling induced by CRT, the alteration in intrinsic QRS (iQRS) duration is a useful index for the reversal of electrical remodeling. [3] Studies have demonstrated that a shortening of the iQRS duration was associated with better clinical and echocardiographic response. [4] However, investigations of the mechanism of intrinsic electrical remodeling are limited. The aim of the present study was to evaluate the association between cardiac fibrosis and electrical remodeling in patients with a CRT device.
METHODS

Study population
Appropriate patients with a QRS duration ≥120 milliseconds, a baseline New York Heart Association (NYHA) classification of II or III, and a left ventricular ejection fraction ≤35% on optimal medical therapy were prospectively enrolled. Clinical CRT responders were defined as patients alive with a NYHA class improvement ≥1 and no hospitalization for decompensation. Patients who were pacemaker-dependent, or who had less than 90% ventricular pacing, or who had a right ventricular pacing upgraded to CRT, and/ or atrial fibrillation were excluded. Patients with use of anti-arrhythmic drugs other than beta-blockers, right bundle branch block, or an intraventricular conduction disturbance were also excluded. The investigation conformed with the principles outlined in the Declaration of Helsinki and was approved by the local institutional review board; informed consent was obtained from each patient.
Electrocardiogram evaluation
A baseline intrinsic electrocardiogram (ECG) was recorded at a paper speed of 25 mm/second and a caliber of 10 mm/mV before CRT and after 12 months of pacing. In order to record intrinsic ECGs after CRT implantation, the devices were reprogrammed to VVI 40. After 1 minute of native rhythm, a surface ECG was recorded, and then the previous device settings were restored. Reverse electrical remodeling was defined as a decrease in iQRS duration of ≥20 milliseconds after CRT implantation. [4] The delta iQRS duration value between ECGs recorded at the time of implantation and 1 year afterward was used for analysis. Two independent physicians checked all ECG results manually after magnification to 200%. Any disagreement was settled by mutual consent.
Device implantation
The left ventricular lead was implanted in the coronary sinus to achieve permanent epicardial stimulation as described previously. [5] A lateral or posterolateral site was chosen as the primary area if it was accessible, pacing thresholds were sufficient, and phrenic nerve stimulation was absent. The right ventricular lead was implanted in the apex in all patients, and the right atrium lead was implanted in the right atrial appendage. The CRT devices and leads used were manufactured by Medtronic, Inc. (Minneapolis, MN, USA) and Biotronik SE & Co. KG (Berlin, Germany). The pacing mode was set as DDD, which is programmed to maximize biventricular pacing. The coronary sinus lead position, pacing mode, and programming of timing intervals were evaluated at 1, 3, 6, and 12 months after pacemaker implantation. 
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Echocardiography
Serial echocardiography was performed both before and after CRT implantation to assess the degree of left ventricle (LV) reverse remodeling and change in cardiac function. LV end-diastolic volume, LV endsystolic volume, and ejection fraction were assessed using Simpson's equation. Patients were classified as echocardiographic CRT responders if they were alive and showed a ≥15% decrease in LV end-systolic volume (compared with baseline) at the 12-month follow-up visit. [6] Laboratory analysis
Blood samples were obtained from the patients after 30 minutes of bed rest both before CRT implantation and at the 12-month follow-up visit and were stored at -80°C until analysis. The biomarkers assessed were galectin-3 (BMS279/2; Bender MedSystems, Vienna, Austria), growth differentiation factor-15 (GDF-15) (RD191135200R; Biovendor Research and Diagnostic Products, Brno, Czech Republic) and procollagen III N-terminal propeptide (P3TD) (E0573Hu; USCN Life Science Inc., Wuhan, China). All blood samples were processed according to manufacturer's instructions and spectrophotometrically read on a SpectraMax M2 reader (Molecular Devices, Inc., Silicon Valley, CA, USA).
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics for Windows, Version 20 (IBM Corp., Armonk, NY, USA). All variables were examined with regard to distributional properties using the ShapiroWilk test, visual inspection, and assessment of kurtosis and skew. Normally distributed continuous variables were analyzed using Student's t-test and expressed as mean±SD. Abnormally distributed continuous variables were analyzed using the Mann-Whitney U test and expressed as median (interquartile range [IQR] ). Categorical variables were presented as percentages and analyzed using Fisher's exact test or a chisquare test (with continuity correction). Time-related changes in electro-echocardiographic parameters and biomarker levels were analyzed with general linear model-repeated measures and the Bonferroni test adjustment. Spearman correlation analysis was used to assess the correlations between the time-related changes (delta) in QRS duration and biomarker levels. Furthermore, a multivariable, repeated-measure, mixed-effect regression model was used to determine the significant independent predictors of delta QRS duration (electrical response). A p value of <0.05 was considered statistically significant.
RESULTS
Patient characteristics
A total of 41 patients (28 male; mean age: 61.00±11.89 years) who were referred to the center for CRT device implantation were enrolled. A biventricular ICD was implanted in all of the study patients. Reverse electrical remodeling according to the predefined criteria was detected in 16 (39.0%) patients, and the remaining 25 (61.0%) did not have electrical remodeling. There was no significant difference between the responders and non-responders in terms of age, gender, risk factors, or echocardiographic features. All patients had sinus rhythm and left bundle branch block (LBBB); 16 (39%) had ischemic cardiomyopathy and 25 (61.0%) had non-ischemic cardiomyopathy. Baseline characteristics of the study population are listed in Table 1 .
Follow-up
During the follow-up period, 29 (70.7%) patients were echocardiographic responders and 12 (29.3%) were echocardiographic non-responders. There were 30 (73.2%) patients with clinical response and 12 (29.3%) who were clinical non-responders. The distribution of clinical, echocardiographic, and electrocardiographic responses is illustrated in Figure 1 . Six patients did not respond clinically, electrically, or echocardiographically. Two of these 6 patients were hospitalized once as a result of decompensation. One patient was added to a heart transplant program; however, heart transplantation was not performed during the study period. During the follow-up period, no study patients underwent surgical or percutaneous revascularization. In all of the study patients, paced QRS duration just after CRT implantation was significantly shorter than QRS duration prior to CRT mL) (p<0.001) and from 125 mL (IQR: 104-191 mL) to 115 mL (IQR: 81-158 mL) (p<0.001), respectively. The ejection fraction increased from 27.1±4.9% to 33.2±8.3% (p<0.001) after 12 months of biventricular pacing ( Table 2 ). Resolution of LBBB was observed in 1 patient.
Laboratory analysis
Analysis of the electrical responders showed that at the 12-month follow-up visit, the level of galectin-3, GDF-15, and P3TD was significantly lower than at baseline. In the electrical non-responders, the level of these biomarkers did not change significantly at the 12-month follow-up. Detailed results are provided in tive QRS narrowing was associated with a beneficial response and greater improvements in echocardiography. They concluded that abbreviation of the native QRS duration was an important sign for electrical remodeling imposed by CRT.
Several biomarkers are used to detect the underlying molecular pathophysiology of the disease condition. We evaluated cardiac fibrosis to investigate the underlying mechanism of electrical remodeling. P3TD is released during collagen biosynthesis and it is a useful marker of active myocardial collagen synthesis. A number of studies have demonstrated that a high level of circulating P3TD was predictive of death and hospitalization in heart failure patients. [12, 13] Galectin-3 is involved in the mechanisms of fibrogenesis in a failing heart and is associated with extracellular matrix turnover. The level of galectin-3 also predicts long-term mortality in patients with heart failure. [14] As a stress-responsive cytokine, GDF-15 plays a pivotal role in the development and progression of cardiovascular diseases such as heart failure, coronary artery diseases and atrial fibrillation. It has been demonstrated that circulating GDF-15 was significantly correlated with the severity of myocardial fibrosis. [15, 16] In the present study, we found that there was a significant decrease in fibrosis biomarker levels in the electrical responder group and no significant decrease in the electrical non-responder group. Although the exact mechanism of the narrowing of the native QRS duration is unclear, any abnormality in collagen metabolism may also be deleterious to cardiac function, as the resultant fibrotic changes can cause ventricular dysfunction and conduction abnormalities. [17] Conversely, mechanical remodeling with smaller chamber sizes may lead to a recovery of collagen metabolism, and result in an improvement in systolic functions and conduction properties.
One of the points to be noted is that electrical and echocardiographic remodeling may not always coexist. Patients without electrical remodeling on native ECG may exhibit improvements in echocardiography, and vice versa. Accordingly, 44.8% of responders and 25.0% of non-responders had native QRS narrowing post-CRT in our patient cohort. In addition, the B-type natriuretic peptide level did not significantly differ between the groups with and without electrical remodeling. This variation might be attributed to the differences in individual substrates, inhomogeneity delta end-diastolic volume (rho=0.403; p=0.024) and the delta end-systolic volume (rho=0.576; p=0.022). In the multivariable, repeated-measure, mixed-effect regression model, the delta galectin-3 level and the delta GDF-15 level were independent predictors of electrical response [beta±SE: 1.48±0.6, 95% confidence interval (CI): 0.159-2.811; p=0.031 and beta±SE: 0.41±0.2, 95% CI: 0.009-2.811; p=0.046, respectively].
DISCUSSION
The results of this study demonstrated that reverse electrical remodeling after CRT implantation was associated with decreased cardiac fibrosis. CRT emerged as an electrical therapy, and there has not been much investigation of any association between the reversal of underlying electrical dyssynchrony and cardiac fibrosis. To our knowledge, this is the first study to investigate cardiac fibrosis in patients with CRT implantation.
CRT is an effective treatment option in appropriately selected heart failure patients. The duration and waveform of the QRS complex are the most valuable predictors of CRT response. Wider QRS duration and LBBB morphology provide the appropriate background for resynchronization and are frequently associated with a favorable response to CRT. [7] [8] [9] In addition to the baseline QRS duration, several studies have indicated that QRS narrowing after initiation of biventricular pacing also predicted beneficial outcomes for CRT. Abbreviation in the QRS duration on biventricular pacing ECG was taken as a sign of rectification of electrical dyssynchrony produced directly by CRT and the amount of abbreviation in paced QRS duration has been positively associated with a therapeutic response to CRT. [10, 11] There has also been increasing interest in the iQRS duration in recent years, as well as the baseline and paced QRS duration. There are various limitations to the evaluation of paced QRS duration. Namely, paced QRS is formed by the fusion of propagation originating from different ventricular pacing locations and represents the instant and direct effects of CRT. For these reasons, it has been suggested that the duration of paced QRS is not the best indicator of the underlying electrical remodeling. In contrast, alteration in the iQRS duration is far superior to paced QRS duration when assessing reversal of electrical dyssynchrony. Yang et al. [3] reported that na-of electrical dyssynchrony, and dissociation between mechanical and electrical dyssynchrony. [18, 19] 
Limitations
The main limitation of our study is the small sample size, but this was the first study to evaluate cardiac fibrosis in electrical remodeling. Secondly, the current guidelines include a class I recommendation for CRT in patients with a QRS duration ≥150 milliseconds.
Only two-thirds of the patients in the present study met this criterion. Thirdly, as blood samples were obtained at only 2 time points, i.e., upon entering the study and at the 12-month follow-up, it is possible that some information on the time course of these markers may have been missed. Finally, use of more rigorous methods than an enzyme-linked immunosorbent assay test will yield more accurate results.
Conclusion
Cardiac fibrosis markers decreased after 1 year of biventricular pacing in patients with electrical remodeling. These results suggest that improvement in cardiac fibrosis plays an important role in electrical remodeling in patients with CRT. The results of our study merit further research.
